Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,642.00
+8.40 (0.51%)
Jun 6, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2017 - 2018 |
| Generic Injectibles | 56.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Generic Injectibles Growth | 56.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2017 - 2018 |
| United States | 26.88B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 28.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World | 11.82B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Growth | 71.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 10.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 462.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 5.88B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 5.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | 890.27M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | 12.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia | 626.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia Growth | 187.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Zealand | 28.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Zealand Growth | 159.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|